An experimental Maze Therapeutics drug increased urinary excretion of compounds that are biological indicators of metabolic disease, early clinical trial results that suggest the molecule has ...
Sanofi has two therapies for the rare disorder Pompe disease, one of which is a relatively recent entry into the market. But a drug candidate from Maze Therapeutics would offer advantages over both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback